Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
US Average Aggregate Net Prices Declined 7.8%
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
You may also be interested in...
Sanofi's US net drug prices declined 1.3% in 2021, the smallest decline in six years of publicly disclosing aggregate list and net price information.
Vaccine spending projections represent about 2% of total spending on medicines IQVIA said. Increased spending will be partly offset by COIVD-19 disruptions, however.
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.